What do biomarkers mean for the treatment of Alzheimer’s disease?

Liana Apostolova, MD, MS from Indiana University School of Medicine, Indianapolis, IN gives us an overview of how biomarkers can be important in identifying the pathogenesis of Alzheimer’s disease, and explains their value in treating Alzheimer’s patients. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.

Share this video